-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-refinement_methods.pdf
January 01, 2013 - None of the authors has a financial interest in any of the products discussed in this document
Suggested … We discussed each issue until we
reached agreement.
Results. … and
recruiting Key Informants, facilitating engagement, synthesis, and reporting are described and
discussed … We discussed each of the items during eighteen 90-minute teleconference meetings over 12
months. … meetings were audio recorded, and detailed minutes of the meetings were
subsequently reviewed and discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-249-malnutrition-disposition-comments_0_0.pdf
October 13, 2021 - Disposition of Comments_Comparative Effectiveness Review No. 249: Malnutrition in Hospitalized Adults: A Systematic Review
Comparative Effectiveness Review Disposition of Comments Report
Title: Malnutrition in Hospitalized Adults: A Systematic Review
Draft report available for public comment from Jun…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_disposition-comments.pdf
May 08, 2013 - The aspect being discussed is
tailoring the interventions to the level and type of risk, rather
than … Results Page 83, the interaction of nonbreatheable incontinence pads
on low air loss beds needs to be discussed … The lack of studies in many areas is discussed in the section
"Limitations of the Evidence Base." … However, the methodological design
(discussed below) restricts the ability of this review to do as
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
February 01, 2012 - The Schroy study is
discussed as part of Key Question 4. … The QuARTS platform
discussed above was designed to discriminate MT and WT at the
level of 1:10,000 … The Schroy study is
discussed as part of Key Question 4. … The QuARTS platform
discussed above was designed to discriminate MT and WT at the
level of1:10,000. … What are the most important
issues discussed for new tests/test versions going forward?
-
effectivehealthcare.ahrq.gov/sites/default/files/technical-brief-34-health-worker-certification-comments.pdf
March 27, 2020 - favor of certification; as described for
each of our key questions, some grey
literature documents discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/postpartum-care-one-year-disposition-comments.pdf
June 02, 2023 - Disposition of Comments_Comparative Effectiveness Review No. 261_Postpartum Care up to 1 Year After Pregnancy: A Systematic Review and Meta-analysis
Comparative Effectiveness Review Disposition of Public Comments Report
Project Title: Postpartum Care up to 1 Year After Pregnancy: A Systematic Review an…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_disposition-comments.pdf
June 12, 2012 - We have discussed the influence of functional
capacity on NIT testing in the Introduction. … Areas where insufficient
data were present were clearly stated, and these areas were then
discussed … Bruening, Wendy Summary
and
Discussion
A limitation of the evidence base that isn't discussed in … practice should also be discussed. … We agree and have already discussed layered
testing in the Discussion section.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
September 25, 2013 - As discussed in the “General
Considerations” section we make every effort to follow a
systematic and … As discussed below, most large
“repurposed RCTs” were based on large well-conducted
RCTs assessing … This decision was discussed with
our Key Informants and was pre-specified in the review
protocol. … However these studies are not discussed in
sufficient detail or a synthesis provided in the executive … Information on blinding has been extracted and is
discussed in the Results section of the Final Report
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
May 13, 2014 - TEP
Reviewer
#3
Discussion/
Conclusion
Page 90, Genetic Polymorphisms: As discussed above, personalized
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/transitions-care-pediatric-to-adult-services-disposition-comments.pdf
May 31, 2022 - informing this topic may not be published
in the expected peer-reviewed journals or many
have been discussed … Our methodological approach along with the study inclusion
and exclusion criteria was discussed with
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/documentation-burden-prepub-disposition-comments.pdf
May 21, 2024 - Some additional context may be helpful as discussed
in the above comments.”
Thank you. … Then,
efforts could be directed toward ideas being discussed among
experts as which tested ones to … The breadth and variety of data and information needed to
move forward is discussed clearly and is informative … Section Comment Response
KI Reviewer 2: Summary and
Implications
Wondering if any of the articles discussed … The number of tasks
is different from the other noted type of measures discussed in
the 3.3.1.2 Activities
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_disposition-comments.pdf
July 01, 2012 - Discussion/
Conclusion
4) In general, the implications and limitations of the review are clearly
discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-outcome-measure-harmonization-depression.pdf
November 01, 2020 - Because these questions are relevant to both registries, they are discussed further in
the Key Findings … Questions identified during this process are discussed further in the Key Findings section below. … Capture of the PHQ-9 requires operational and technical modifications
These findings are discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
June 07, 2013 - Summary Outcome measures are well defined and appear
appropriate, however on p. 52 where harms are
discussed … As discussed previously, the number of citations is
limited in the Executive Summary; specific relevant … studies (or in my reading, I missed this
statement), if you are making a point here, then it should
be discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-outpatient-setting-comments.pdf
March 22, 2021 - Disposition of Comments: Comparative Effectiveness Review No. 238 Cervical Ripening in the Outpatient Setting
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Cervical Ripening in the Outpatient Setting
Draft report available for public comment from August 13, 2020…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
January 01, 2014 - The relationship between the triple therapy results
and the guidelines is more fully discussed in the … Chapell, Richard Executive
Summary
For the reasons discussed under “Introduction”, please include … This application is discussed
in the analyses. … In addition to the discussion of bleeding events in the
Introduction, wherever bleeding events are discussed … Chapell, Richard Figures As discussed under “Introduction, please add GPIs as a
treatment option when
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-232-breathlessness-cancer-comments.pdf
November 19, 2020 - should include definitions of
Thank you
We appreciate the challenges of this definition: this was
discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-disposition-comments.pdf
November 01, 2022 - Research Review Title: Infection Prevention and Control for the Emergency Medical Services and 911 Workforce
Technical Brief Disposition of Comments Report
Research Review Title: Infection Prevention and Control for the Emergency Medical Services
and 911 Workforce
Draft report available for p…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
March 07, 2012 - This change in JIA criteria
should be discussed / clarified to be consistent. … However, Table 1 is
not referred to until the next paragraph where they
discussed the second level
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
February 25, 2014 - The inclusion criteria were very strict,
and as discussed above the conclusions are not written for … Instead, this should be
discussed as an issue of precision and be based on the body of (pooled) evidence